Jade Biosciences (JBIO) Operating Leases (2021 - 2026)
Jade Biosciences (JBIO) reported Operating Leases of $700000.0 for Q1 2026, down 3.31% quarter-over-quarter from $724000.0 in Q4 2025.
Jade Biosciences (JBIO) Operating Leases (2021 - 2026) Analysis & Trends
Jade Biosciences has reported Operating Leases for 6 years, with the latest figure at $700000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $700000.0 (changed N/A YoY), and the FY2025 full-year result was $724000.0, changed N/A from the prior year.
- Operating Leases for Q1 2026 stood at $700000.0, down from $724000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.2 million in Q2 2022, with the low at $81000.0 in Q3 2024.
- Historically, Operating Leases has averaged $566733.3 across 5 years, with a median of $591000.0 in 2023.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 77.37% — and 2025, when it jumped 822.22%.
- Jade Biosciences' Operating Leases stood at $705000.0 in 2022, then tumbled by 63.83% to $255000.0 in 2023, then plunged by 68.24% to $81000.0 in 2024, then soared by 793.83% to $724000.0 in 2025, then dropped by 3.31% to $700000.0 in 2026.
- The last three Operating Leases figures came in at $700000.0 (Q1 2026), $724000.0 (Q4 2025), and $747000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Jade Biosciences | 877.06 Mn | 877.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 724,000.00 |
| Sep 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 792,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 255,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 476,000.00 |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 705,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 528,000.00 |
| Dec 31, 2021 | 382,000.00 |
| Sep 30, 2021 | 452,000.00 |